Efficiency of modern correction methods of ovarian hyperandrogenism in puberty

Abstract

Aim. To evaluate the effectiveness of correction of the ovarian hyperandrogenism (OHA) in girls in puberty.

Methods. 38 girls with OHA syndrome were examined. The average age of the girls was 14.39 ± 0.27 years. Ferriman-Gallwey hirsutism score was 19.7 ± 0.47, the hormonal score 18.14 ± 2.43, the indifferent score 2.34 ± 0.13. The comparison group included 20 girls matched by age (14.74 ± 0.15 years) with physiological course of puberty. The study included the evaluation of hirsutism severity by Ferriman-Gallway score, determination of the hormones of hypothalamus-pituitary-adrenal-ovarian system in early follicular phase on day 5-7 of menstrual cycle.

Results. The causes of OHA syndrome in the pubertal period were found to be polycystic ovary syndrome in 68.42 % and tumor-like formations (follicular cysts) in 31.58 % of girls. Compared to healthy girls, the girls with OHA syndrome had statistically significantly higher values of luteinizing hormone (LH) - 9.19 ± 0.96 mME/ml, LH/FSH ratio - 1.8 ± 0.15, total testosteron (Ttotal) - 1.3 ± 0.11 ng/ml, estrone (E1) - 109.5 ± 4.88 ng/ml, androstenedione (An) - 4.01 ± 0.12 ng/ml as well as low values of estradiol (E2) - 49.1 ± 2.6 pg/ml and sex hormone-binding globulin (SHBG) - 45.7 ± 2.14 nmol/l. The study demonstrated that correction of ovarian hyperandrogenism, promotes an increase in the level of E2, SHBG and decrease of the level of LH, LH/FSH ratio, Ttotal, An.

Conclusion. Complex pathogenetic therapy of OHA syndrome in girls in puberty leads to significant improvement of hormonal status in this group of patients.

Keywords

hyperandrogenism syndrome / hirsutism / puberty / polycystic ovary syndrome

References

[1] Volkova N.I., Dimitriaidi T.A. Diaqnosis of the syndrome of hyperandrogenism in real practice (retrospective analysis). Farmateka. 2009; 17: 48–51. (In Russ.)

[2] Волкова Н.И., Димитриаиди Т.А. Диагностика синдрома гиперандрогении в реальной практике (ретроспективный анализ). Фарматека. 2009; 17: 48-51.

[3] Rafieva Z.Kh., Abdurakhmanova F.M. Endocrine disorders in girls with psychoemotional stress. Vserossiyskiy vestnik akushera-ginekologa. 2009; 9 (4): 51–55. (In Russ.)

[4] Рафиева З.Х., Абдурахманова Ф.М. Эндокринные нарушения у девушек, перенесших психоэмоциональный стресс. Всероссийский вестник акушера-гинеколога. 2009; 9 (4): 51-55.

[5] Yildiz B.O., Bolour S., Woods K., Moore A., Azziz R. Visualy scoring hirsutism. Hum. Reprod. Update. 2010; 16 (1): ­51–64. DOI: 10.1093/humupd/dmp024.

[6] Yildiz B.O., Bolour S., Woods K., Moore A., Azziz R. Visualy scoring hirsutism. Hum. Reprod. Update. 2010; 16 (1): 51-64. DOI: 10.1093/humupd/dmp024.

[7] Amalfi S., Velez L.M., Heber M.F. Prenatal hyper­androgenization induces metabolic and endocrine alterations which depends on the level of testosterone exposure. PloS One. 2012; 7 (5): 37658. DOI: 10.1371/journal.pone.0037658.

[8] Amalfi S., Velez L.M., Heber M.F. Prenatal hyperandrogenization induces metabolic and endocrine alterations which depends on the level of testosterone exposure. PloS One. 2012; 7 (5): 37658. DOI: 10.1371/journal.pone.0037658.

[9] Aminzadeh M., Kim H.G., Layman L.C. Rarer syndromes characterized by hypogonadotropic hypogonadism. Front. Horm. Res. Basel, Karger. 2010; 39: 154–167. DOI: 10.1159/000312701.

[10] Aminzadeh M., Kim H.G., Layman L.C. Rarer syndromes characterized by hypogonadotropic hypogonadism. Front. Horm. Res. Basel, Karger. 2010; 39: 154-167. DOI: 10.1159/000312701.

[11] Bals-Pratsch M., Seifert B., Ortmann O. Genetic Causes in Adrenal or Ovarian Hyperandrogenism in the Reproductive Years. Am. J. Reproduktionsmed. Endokrinol. 2009; 6 (1): ­19–23.

[12] Bals-Pratsch M., Seifert B., Ortmann O. Genetic Causes in Adrenal or Ovarian Hyperandrogenism in the Reproductive Years. Am. J. Reproduktionsmed. Endokrinol. 2009; 6 (1): 19-23.

[13] Carmina E., Oberfield S., Lobo R. The diagnosis of polycystic ovary syndrome in adolescents. Am. J. Obstet. Gynecol. 2010; 203: 1–5. DOI: 10.1016/j.ajog.2010.03.008.

[14] Carmina E., Oberfield S., Lobo R. The diagnosis of polycystic ovary syndrome in adolescents. Am. J. Obstet. Gynecol. 2010; 203: 1-5. DOI: 10.1016/j.ajog.2010.03.008.

[15] Panarina O.V., Rashidova M.A., Belen'kaya L.V, Trofimova T.A., Sholokhov L.F. Modern concepts of the pathogenesis of polycystic ovary syndrome (literature review). Acta Biomedica Scientifica. 2017; 2 (4): 9–14. (In Russ.)

[16] Панарина О.В., Рашидова М.А., Беленькая Л.В., Трофимова Т.А., Шолохов Л.Ф. Современные представления о патогенезе синдрома поликистозных яичников (обзор литературы). Acta Biomedica Scientifica. 2017; 2 (4): 9-14. . DOI: 10.12737/article_59fad50f053c20.99807656.

[17] article_59fad50f053c20.99807656.

[18] Hickey M., Sloboda D.M., Atkison N.C. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence. J. Clin. Endocrinol. Metab. 2009; 94 (10): 3714-3720. DOI: 10.1210/jc.2009-0544.

[19] Hickey M., Sloboda D.M., Atkison N.C. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence. J. Clin. Endocrinol. Metab. 2009; 94 (10): 3714–3720. DOI: 10.1210/jc.2009-0544.

[20] Zachurzok A., Deja G., Gawlik A., Drosdzol-Cop A. Hyperandrogenism in adolescent girls with type 1 diabetes mellitus treated with intensive and continuous subcutaneous insulin therapy. Endokrinol. Pol. 2013; 64 (2): 121-128. PMID: 23653275.

[21] Zachurzok A., Deja G., Gawlik A., Drosdzol-Cop A. Hyperandrogenism in adolescent girls with type 1 diabetes mellitus treated with intensive and continuous subcutaneous insulin therapy. Endokrinol. Pol. 2013; 64 (2): 121–128. PMID: 23653275.

[22] Nafiye Y., Sevtap K., Muammer D., et al. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome. Fertil. Steril. 2010; 93 (6): 1864-1869. DOI: 10.1016/j.fertnstert.2008.12.024.

[23] Nafiye Y., Sevtap K., Muammer D., et al. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome. Fertil. Steril. 2010; 93 (6): 1864–1869. DOI: 10.1016/j.fertnstert.2008.12.024.

RIGHTS & PERMISSIONS

Alieva E.M., Akhundova N.E.